Scarica l'app Stockscreener
18.34
1.72%
0.31
Dopo l'orario di chiusura:
18.34
Precedente Chiudi:
$18.03
Aprire:
$18.08
Volume 24 ore:
2.39M
Relative Volume:
0.77
Capitalizzazione di mercato:
$4.36B
Reddito:
$474.17M
Utile/perdita netta:
$208.93M
Rapporto P/E:
21.59
EPS:
0.8493
Flusso di cassa netto:
$65.61M
1 W Prestazione:
-0.11%
1M Prestazione:
-7.61%
6M Prestazione:
+0.33%
1 anno Prestazione:
-4.13%
Intervallo 1D:
$17.88
$18.55
Intervallo di 1 settimana:
$17.45
$18.75
Portata 52W:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Nome
Adma Biologics Inc
Settore
Industria
Telefono
(201) 478-5552
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Confronta ADMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
18.34 | 4.29B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-19 | Ripresa | Raymond James | Strong Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Iniziato | Jefferies | Buy |
| 2019-04-15 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-07 | Ripresa | H.C. Wainwright | Buy |
| 2017-12-11 | Reiterato | Maxim Group | Buy |
| 2017-11-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2016-08-01 | Downgrade | Maxim Group | Buy → Hold |
| 2016-07-25 | Reiterato | Maxim Group | Buy |
| 2015-05-13 | Reiterato | Maxim Group | Buy |
| 2014-12-08 | Iniziato | Oppenheimer | Outperform |
| 2014-12-01 | Reiterato | Maxim Group | Buy |
Mostra tutto
Adma Biologics Inc Borsa (ADMA) Ultime notizie
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - Yahoo Finance
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 - The Manila Times
Why (ADMA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Allspring Global Investments Holdings LLC Sells 1,772,112 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics IncCommon Stock (NQ: ADMA - FinancialContent
ADMA Biologics Inc $ADMA Shares Sold by Calamos Advisors LLC - MarketBeat
Does Kizi Apparels Limited Have a Competitive Advantage in Its SectorREITs Market Trends & Free Popular Stock Picks Selection - earlytimes.in
ADMA Biologics Earnings Notes - Trefis
ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade - ts2.tech
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - The Motley Fool
Harbor Capital Advisors Inc. Buys Shares of 59,801 ADMA Biologics Inc $ADMA - MarketBeat
Rice Hall James & Associates LLC Has $4.75 Million Stake in ADMA Biologics Inc $ADMA - MarketBeat
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - MSN
(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
High Growth Tech Stocks To Watch In US December 2025 - simplywall.st
The Bull Case For ADMA Biologics (ADMA) Could Change Following Its Higher 2025 Revenue Outlook Revision - Sahm
Adma Biologics Receives Upgraded Price Target on Strong Outlook - AD HOC NEWS
Assessing ADMA Biologics (ADMA) Valuation After Its Upgraded 2025 Revenue Guidance - Sahm
ADMA Biologics (ADMA): Firm updates 2025 revenue guidance - MSN
ADMA Biologics Inc $ADMA Shares Bought by Voya Investment Management LLC - MarketBeat
Texas Permanent School Fund Corp Has $1.87 Million Holdings in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA): Firm Updates 2025 Revenue Guidance - Finviz
Should You Be Adding ADMA Biologics (NASDAQ:ADMA) To Your Watchlist Today? - Yahoo Finance
How ADMA Biologics Inc. stock valuations compare to rivalsJuly 2025 Breakouts & Verified Swing Trading Watchlists - Улправда
Fed Meeting: Will ADMA Biologics Inc. stock outperform growth indexes2025 Pullback Review & Long-Term Growth Stock Strategies - Улправда
Published on: 2025-12-21 05:20:22 - Улправда
Perpetual Ltd Cuts Stake in ADMA Biologics Inc $ADMA - MarketBeat
Jobs Data: How ADMA Biologics Inc. stock valuations compare to rivalsPortfolio Gains Report & Advanced Technical Analysis Signals - Улправда
Will ADMA Biologics Inc. stock gain from lower inflationJuly 2025 Reactions & Risk Controlled Stock Pick Alerts - DonanımHaber
Published on: 2025-12-19 13:57:53 - Улправда
Decliners Report: Can ADMA Biologics Inc. stock sustain free cash flow growth2025 Winners & Losers & Low Risk High Reward Ideas - DonanımHaber
Can ADMA Biologics Inc. stock sustain revenue growthWeekly Loss Report & Low Volatility Stock Suggestions - Улправда
What analyst consensus says on ADMA Biologics Inc. stock2025 Valuation Update & Fast Gaining Stock Reports - Улправда
CEO Grossman Sells 21,000 ($415.6K) Of Adma Biologics Inc [ADMA] - TradingView — Track All Markets
ADMA Biologics (ADMA) CEO trades stock under Rule 10b5-1 plan - Stock Titan
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - MSN
Thrivent Financial for Lutherans Raises Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Does ADMA’s Upgraded EPS Outlook And Higher-Yield Manufacturing Change The Bull Case For ADMA Biologics (ADMA)? - Sahm
ADMA Biologics Inc $ADMA Shares Purchased by Ranger Investment Management L.P. - MarketBeat
Cim LLC Acquires New Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Precision Trading with Adma Biologics Inc (ADMA) Risk Zones - Stock Traders Daily
ADMA Biologics Inc $ADMA Holdings Decreased by AWM Investment Company Inc. - MarketBeat
The Play On ADMA Biologics: A Discounted Stock With Good Prospects (NASDAQ:ADMA) - Seeking Alpha
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - MSN
Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Osterweis Capital Management Inc. Takes $5.40 Million Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Purchased by Marathon Capital Management - MarketBeat
Federated Hermes Inc. Has $17.06 Million Stake in ADMA Biologics Inc $ADMA - MarketBeat
Arrowstreet Capital Limited Partnership Cuts Stake in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ophir Asset Management Pty Ltd Boosts Position in ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):